GlassScriptPhysician profile
Mary Kim
NPI 1275720930
$1,512.08
in general payments reported to CMS, 2019-2025
11 companies · $901 in 2025
The $901 reported for 2025 was more than what 78% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $141 · 2023: $13.68 · 2024: $456 · 2025: $901.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,371.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $334.24 | 2024 | Xarelto |
| Inspire Medical Systems, INC. | $149.99 | 2025 | Inspire |
| Stryker Corporation | $140.82 | 2022 | |
| Globus Medical, INC. | $132.82 | 2025 | Senza |
| Phathom Pharmaceuticals, INC. | $124.99 | 2025 | Voquezna |
| Corcept Therapeutics | $124.98 | 2025 | Korlym |
| Amgen INC. | $124.92 | 2025 | Evenity |
| Gilead Sciences, INC. | $122.07 | 2024 | Veklury |
| Axsome Therapeutics, INC. | $121.79 | 2025 | Auvelity |
| Dexcom, INC. | $121.78 | 2025 | Dexcom G6 Transmitter |
| Abbvie INC. | $13.68 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.